6-Gingerol

製品コードS3836 バッチS383601

印刷

化学情報

Chemical Structure Synonyms N/A Storage
(From the date of receipt)		 3 years -20°C powder
1 years -80°C in solvent
化学式

C17H26O4
分子量 294.39 CAS No. 23513-14-6
Solubility (25°C)* 体外 DMSO 58 mg/mL (197.01 mM)
 
 
体内 （毎回新しく調製した物を用意してください）
Clear solution
5%DMSO Corn oil
2.9mg/ml Taking the 1 mL working solution as an example, add 50 μL of 58 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 6-Gingerol is the active constituent of fresh ginger known to exhibit a variety of biological activities including anticancer, anti-inflammation, and anti-oxidation.
in vitro 6-gingerol treatment significantly reduces the cell viability of human colon cancer cell, LoVo, in a dose-dependent manner. 6-gingerol induces significant G2/M phase arrest and has slight influence on sub-G1 phase in LoVo cells. Levels of cyclin A, cyclin B1, and CDK1 are diminished; in contrast, levels of the negative cell cycle regulators p27Kip1 and p21Cip1 are increased in response to 6-gingerol treatment. In addition, 6-gingerol treatment elevates intracellular reactive oxygen species (ROS) and phosphorylation level of p53. 6-gingerol is effective in suppressing the transformation, hyperproliferation, and inflammatory processes that initiate and promote carcinogenesis, as well as the later steps of carcinogenesis, namely, angiogenesis and metastasis[1]. 6-gingerol has direct cytotoxic effects on cultures of tumor cells, such as colorectal cancer cells, HL-60 cells and breast cancer cells[2].
in vivo 6-gingerol inhibits tumor growth in several types of murine tumors, such as B16F1 melanomas, Renca renal cell carcinomas and CT26 colon carcinomas, established by inoculating tumor cells on the flanks of mice, although it does not lead to complete eradication of the tumors. 6-gingerol treatment of tumor-bearing mice causes massive infiltration of CD4 and CD8 T-cells and B220+ B-cells, but reduces the number of CD4+Foxp3+ regulatory T-cells. The CD8 tumor-infiltrating T lymphocytes in 6-gingerol-treated mice strongly express IFN-γ, a marker of activation of CTL CD107a cells, and chemokine receptors that are expressed on TH1 cells, such as CXCR3 and CCR5[2].

プロトコル(参考用のみ)

細胞アッセイ 細胞株 Colon cancer cell line LoVo
濃度 1, 5, 10, and 15 μg/mL
反応時間 24 h or 48 h
実験の流れ Colon cancer cell line LoVo is maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% v/v fetal bovine serum, 1% nonessential amino acid, 1% L-glutamine, and 100 μg/mL penicillin/streptomycin at 37°C in a humidified atmosphere with 5% CO2. Cells are seeded in 10 cm Petri dishes at an initial density of 2×105 cells/mL and grown to approximately 80% confluence. Then, the cells are collected for the subsequent analyses including cell viability, flow cytometric analysis, and immunoblotting analysis. For 6-gingerol treatments, cells are starved for 24 hours (h) in serum-free DMEM and then incubated with 6-gingerol at a series of concentrations in serum-free DMEM (1, 5, 10, and 15 μg/mL) for 24 h or 48 h.
動物実験 動物モデル Female Balb/c and C57BL/6 mice (Mice areinoculated with 3.0×105 CT26 cells, 7×105 Renca cells [Balb/c], or 2.5×105 B16F1 cells [C57BL/6] in the left flank）
投薬量 3 μg/ml
投与方法 p.o.

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

6-Gingerol Improves In Vitro Porcine Embryo Development by Reducing Oxidative Stress [ Animals (Basel), 2023, 13(8)1315] PubMed: 37106877
6-Gingerol suppresses tumor cell metastasis by increasing YAPser127 phosphorylation in renal cell carcinoma [ J Biochem Mol Toxicol, 2020, e22609] PubMed: 32926756
6-Gingerol induces cell-cycle G1-phase arrest through AKT-GSK 3β-cyclin D1 pathway in renal-cell carcinoma. [ Cancer Chemother Pharmacol, 2020, 85(2):379-390] PubMed: 31832810

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。